Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 59
Improving Civilian Medical Response to Chemical or Biological Terrorist Incidents: Interim Report on Current Capabilities APPENDIX A Committee Biographies Peter Rosen (chair), M.D., FACS, FACEP, is Director of Emergency Medicine Residency Program at the University of California, San Diego. Dr. Rosen previously served as chair of the IOM Committee on Treatment of Near-Drowning Victims. He has authored or edited a dozen textbooks on aspects of emergency medicine and since 1983 has served as Editor-in-Chief of the Journal of Emergency Medicine. He is a Fellow of the American College of Surgeons, the American College of Emergency Physicians, and the American Burn Association. Leo G. Abood, Ph.D., is Professor of Pharmacology, Department of Pharmacology and Physiology, University of Rochester Medical Center. Dr. Abood is an expert on the biochemistry and physiology of the nervous system whose research has focused on the isolation and characterization of neurotransmitter receptors from the mammalian brain, specifically nicotine, vasopressin, and opioid receptors. He previously served on the NRC Committee on Toxicology's Panel on Anticholinergic Compounds and the Chemical Weapons Stockpile Assessment Panel. Georges C. Benjamin, M.D., FACP, FACEP, is Deputy Secretary for Public Health Services, State of Maryland. Dr. Benjamin is former Commissioner for District of Columbia Public Health; former Chair, Ambulatory Care, D.C. General Hospital; and former Chief, Emergency Medicine, Walter Reed Army Medical Center. He is an Advanced Trauma Life Support Instructor, and a Fellow of the American College of Physicians and the American College of Emergency Physicians. Rosemarie Bowler, Ph.D., is Assistant Professor and Fieldwork Coordinator, Department of Psychology, San Francisco State University. Dr. Bowler has done extensive research on individual and community reactions to toxic chemical spills and has chaired a recent
OCR for page 60
Improving Civilian Medical Response to Chemical or Biological Terrorist Incidents: Interim Report on Current Capabilities symposium on the topic for the Agency for Toxic Substances and Disease Registry. Her clinical experience at SFSU includes assessing patients and groups of workers exposed to neurotoxins. Jeffrey I. Daniels, D.Env., is Risk Sciences Group Leader, Health and Ecological Assessment Division, Earth and Environmental Sciences Directorate, Lawrence Livermore National Laboratory. His expertise is risk assessment and his research involves the potential human health risks from contaminated environmental media, including air, water, soil, vegetation, and the development of a coupled chemical/biological system to degrade high explosives in demilitarization waste water. He is Past-President of the Northern California Chapter of the Society for Risk Analysis. Craig A. DeAtley, B.S., P.A. is Director of the Emergency Medical Services Program, Associate Professor, Department of Emergency Medicine and Health Care Sciences Program, and CoDirector for Hazmat Medical Services, George Washington University. He is also Deputy Medical Director, Flight Medic and SWAT Medic, Fairfax County Police; Medical Specialist, Metropolitan Medical Strike Team DC-1 (PHS-sponsored NBC responders in Washington, D.C. area); and EMS Captain, Fairfax Fire and Rescue. He serves on the editorial boards of Rescue EMS News and Prehospital and Disaster Medicine. Lewis Goldfrank, M.D., FACMT, FACP, FACEP is Director of Emergency Medicine, New York University School of Medicine, Bellevue Medical Center. He is the medical director of the New York City Poison Control Center. Dr. Goldfrank served as president of the Society of Academic Emergency Medicine and chairs the American Board of Emergency Medicine's Subboard on Medical Toxicology. He is coeditor of the Agency for Toxic Substances Disease Registry's Medical Guidelines for Managing Hazmat Incidents, and senior editor of Goldfrank's Toxicologic Emergencies, a standard text in medical toxicology. Jerome M. Hauer, M.H.S., is Director, Office of Emergency Management, City of New York. He previously was Director of Emergency Medical Services and Emergency Mangement for the State of Indiana. He also directed Hazmat response, crisis management, and fire safety for IBM. He is a former Army Captain assigned to the Walter Reed Army Institute of Research and past Chair of the U.S. Earthquake Consortium. Hauer also served on the U.S. Geological Survey ad hoc working group on earthquake-related caualties. He currently serves on the FBI Scientific Advisory Council on Hazardous Materials Response. Karen Larson, Ph.D., is a Toxicologist, Office of Toxic Substances, Washington (State) Department of Health. A molecular biologist, Dr. Larson is the Washington Health Department's liaison with the state emergency planning agency, advising on methods of detection, protection, and treatment in real and hypothetical chemical or biological disasters. Joshua Lederberg, Ph.D., is Sackler Foundation Scholar, Rockerfeller University and Nobel laureate molecular biologist. Dr. Lederberg serves on the NIH Advisory Panel and Defense Science Board, as an advisor to U.S. Marines Chemical/Biological Incident Response Force,
OCR for page 61
Improving Civilian Medical Response to Chemical or Biological Terrorist Incidents: Interim Report on Current Capabilities as Chair of the NAS Working Group on Biological Weapons Control, the NAS Panel on Russian-U.S. Collaborative Program for Research and Monitoring of Pathogens of Global Importance, and the IOM Forum on Emerging Infections. Matthew S. Meselson, Ph.D., is Thomas Dudley Cabot Professor of the Natural Sciences, Department of Molecular and Cellular Biology, Harvard University. Dr. Meselson is a member of the NAS Committee on International Security and Arms Control and the Working Group on Biological Weapons Control. He served on the NAE Committee on Alternative Chemical Demilitarization Technologies and the Advisory Panel on the Chemical Research, Development and Engineering Center. Dennis M. Perrotta, Ph.D., is Chief, Bureau of Epidemiology, Texas Department of Health. Dr. Perrotta administers the Texas Poison Center Network, serves on the Armed Forces Epidemiology Board (AFEB), and recently prepared a report for the AFEB on mustard gas and sarin. In addition, he has served on review sections at NIH and ATSDR and served as a reviewer for the IOM report on Emerging Infectious Diseases. Linda Powers, Ph.D., is Director, National Center for the Design of Molecular Function and Professor of Electrical and Biological Engineering, Utah State University. Dr. Powers holds a Ph.D. in biophysics from Harvard University, and provides expertise in analytical instrumentation, optical and x-ray systems, biosensors, and other onsite monitoring instrumentation. Philip K. Russell, M.D., is Professor of International Health, School of Hygiene and Public Health, Johns Hopkins University. He is former Commander of Army Medical Research and Development. An infectious disease specialist with particular expertise in vaccines, he serves on the Scientific Advisory Board of the National Center on Infectious Disease at the Center for Disease Control and Prevention. Jerome Schultz, Ph.D., is Director, Center for Biotechnology and Bioengineering, University of Pittsburgh. Dr. Shultz is a biochemical engineer with expertise in biochemistry. His research is focused on using biomolecules with recognition capability for biosensor probe devices. He is a past president of the American Institute for Medical and Biological Engineering, and is currently Vice-chair, Board on Army Science and Technology's (BAST) Committee for the Review of Army Chemical and Biological Defense Command. Robert E. Shope, M.D., is Professor, Departments of Pathology and Microbiology and Immunology, University of Texas Medical Branch, Galveston. Dr. Shope is a virologist and former Director of the Arbovirus Research Unit at Yale. Robert S. Tharratt, M.D., FACP, FCCP, FACMT is Associate Professor of Medicine and Chief, Section of Clinical Pharmacology and Medical Toxicology, Division of Pulmonary and Critical Care Medicine, University of California Davis. Dr. Tharratt is also Associate Regional Medical Director of the Davis Division of the California Poison Control System, Medical
OCR for page 62
Improving Civilian Medical Response to Chemical or Biological Terrorist Incidents: Interim Report on Current Capabilities Director of Sacramento County Emergency Medical Services, and Medical Director of the Sacramento City and County Fire Agencies. He is a hazardous materials specialist and a Medical Manager for FEMA Urban Search and Rescue Team CA-7.
Representative terms from entire chapter: